IRIS
SAMBATARO, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.818
AS - Asia 1.459
SA - Sud America 558
EU - Europa 347
AF - Africa 41
OC - Oceania 1
Totale 5.224
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.740
SG - Singapore 588
BR - Brasile 463
HK - Hong Kong 385
CN - Cina 142
VN - Vietnam 138
IE - Irlanda 81
IT - Italia 59
TR - Turchia 51
DE - Germania 42
GB - Regno Unito 36
FR - Francia 35
MX - Messico 35
AR - Argentina 32
IN - India 32
CA - Canada 24
BD - Bangladesh 21
PL - Polonia 21
ID - Indonesia 20
CO - Colombia 17
EC - Ecuador 16
ZA - Sudafrica 16
RU - Federazione Russa 15
ES - Italia 12
IQ - Iraq 11
JP - Giappone 11
SA - Arabia Saudita 11
NL - Olanda 10
UA - Ucraina 9
PY - Paraguay 8
MA - Marocco 7
VE - Venezuela 7
AT - Austria 6
EG - Egitto 6
PK - Pakistan 6
UZ - Uzbekistan 6
CL - Cile 5
KZ - Kazakistan 5
PE - Perù 5
PH - Filippine 5
SE - Svezia 5
FI - Finlandia 4
HN - Honduras 4
MY - Malesia 4
QA - Qatar 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
ET - Etiopia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
AL - Albania 1
BB - Barbados 1
BG - Bulgaria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
IR - Iran 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 5.224
Salva come PNG Salva come JPEG
Città #
Dallas 1.371
Hong Kong 384
San Jose 310
Singapore 281
Ashburn 209
Santa Clara 130
Chicago 122
The Dalles 121
Dublin 81
Ho Chi Minh City 50
Beijing 46
Istanbul 39
São Paulo 30
Hanoi 29
New York 27
Hillsboro 22
Los Angeles 21
Assago 20
Warsaw 19
Mexico City 17
Rio de Janeiro 17
Montreal 11
Belo Horizonte 10
San Francisco 10
Tokyo 10
Düsseldorf 9
Johannesburg 9
Brasília 8
Council Bluffs 8
Frankfurt am Main 8
Manchester 8
Porto Alegre 8
Biên Hòa 7
Brooklyn 7
Curitiba 7
Toronto 7
Chennai 6
Dhaka 6
Hải Dương 6
London 6
Manaus 6
Medellín 6
Seattle 6
Thái Bình 6
Ankara 5
Atlanta 5
Denver 5
Guayaquil 5
Jeddah 5
Lima 5
Limburg an der Lahn 5
Limeira 5
Maceió 5
Nova Iguaçu 5
Palermo 5
Phoenix 5
Reston 5
Rome 5
Thái Nguyên 5
Asunción 4
Baghdad 4
Boston 4
Camaçari 4
Campinas 4
Catania 4
Caxias do Sul 4
Charlotte 4
Doha 4
Fortaleza 4
Helsinki 4
Jakarta 4
Lauterbourg 4
Salvador 4
Santo André 4
Stockholm 4
São Bernardo do Campo 4
Tashkent 4
Addis Ababa 3
Araraquara 3
Bogotá 3
Buenos Aires 3
Cape Town 3
Caracas 3
Cariacica 3
Casablanca 3
Cuiabá 3
Da Nang 3
Franca 3
Joinville 3
Lahore 3
Ludhiana 3
Milan 3
Mogi das Cruzes 3
Montevideo 3
Moscow 3
Mumbai 3
Oklahoma City 3
Orem 3
Osasco 3
Poplar 3
Totale 3.737
Salva come PNG Salva come JPEG
Nome #
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy 83
Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study 79
Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay 79
An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies 67
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis 66
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis from the CLASS project 65
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 60
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 59
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes 59
Radiological Insights into UIP Pattern: A Comparison Between IPF and Non-IPF Patients 58
First-line diagnostic tests to intercept primary heart involvement in systemic sclerosis: Clinical associations from the SPRING-SIR registry 57
Characteristics of emerging new autoimmune diseases after COVID‐19 vaccination: A sub‐study by the COVAD group 57
Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study 57
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 57
Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis 56
Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis 56
Autoimmunity in interstitial lung disease 56
Breakthrough SARS-CoV-2 infection and disease flares in patients with rheumatoid arthritis: result from COVAD e-survey study 55
Patients with interstitial lung disease secondary to autoimmune diseases: How to recognize them? 55
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset 54
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study 54
Chest imaging using signs, symbols, and naturalistic images: a practical guide for radiologists and non-radiologists 54
Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State 53
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank 52
A die-hard giant capillary 52
Prevalence and clinical relevance of digital ulcers in systemic sclerosis patients from the real-life: the experience of the SPRING Registry of the Italian Society for Rheumatology 52
COVAD survey 2 long-term outcomes: unmet need and protocol 51
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 51
Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases 51
Comment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply 51
Pulmonary vasculitides: A radiological review emphasizing parenchymal hrct features 51
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey 50
Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project 50
Experience of a second-level rheumatology clinic during the COVID-19 quarantine 50
Quantification of ground glass opacities can be useful to describe disease activity in systemic sclerosis 49
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 49
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases 47
Nocturnal nasal high-flow oxygen therapy in elderly patients with concomitant chronic obstructive pulmonary disease and obstructive sleep apnea 47
The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis 47
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 47
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study 46
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course 46
Performance of radiomics features in the quantification of idiopathic pulmonary fibrosis from HRCT 46
Immunosuppressive Therapy for Usual Interstitial Pneumonia in Autoimmune Rheumatic Diseases: A Review 46
Primary-Sjögren’s-Syndrome-Related Interstitial Lung Disease: A Clinical Review Discussing Current Controversies 46
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey 45
Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives 45
Renal Resistive Index from Renal Hemodynamics to Cardiovascular Risk: Diagnostic, Prognostic, and Therapeutic Implications 45
Determinants of physical function, as measured using PROMIS PF-10a, in patients with rheumatoid arthritis: results from the international COVID-19 Vaccination in Autoimmune Diseases (COVAD) study 45
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 44
Letter to editor: “Interstitial pneumonia with autoimmune features: Clinical, radiologic and histological characteristics and outcome in a series of 57 patients” 44
Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series 44
Developing PI3K Inhibitors for Respiratory Diseases 43
COVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study 43
Editorial: Multidisciplinary approach to interstitial lung disease associated with systemic rheumatic diseases 43
Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients 42
Quantitative evaluation of fibrosis in ipf patients: Meaning of diffuse pulmonary ossification 42
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-survey 41
Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis 41
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 41
Pleural Irregularities: A new ultrasound marker for lung involvement in primary Sjögren's disease 40
Quantitative assessment of interstitial lung disease in Sjögren’s syndrome 40
NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: A comparison with the proposed composite indices for this disease status entity 40
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: Where to go from here? 39
Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review 39
Cryptogenic organizing pneumonia: Evolution of morphological patterns assessed by HRCT 39
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group 39
Rethinking the need for increased clinical and radiological awareness of incidentally discovered interstitial lung abnormalities on CT chest 39
Tumoural calcinosis of the spine in the course of systemic sclerosis: Report of a new case and review of the literature 39
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study 39
Interstitial Pneumonia with Autoimmune Features (IPAF): time to redefine the classification criteria 38
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? 38
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: A comparative analysis of the COVAD surveys 37
Menstruation-Related Disorders—Dysmenorrhea and Heavy Bleeding—as Significant Epiphenomena in Women With Rheumatic Diseases 37
Interstitial Lung Disease Phenotypes and Predictive Risk Factors in Primary Sjögren’s Syndrome 37
“Usual” interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 35
Prevalence of Progressive Fibrosing Interstitial Lung Disease in Patients with Primary Sjogren Syndrome 35
Hepatic PPARs: Their role in liver physiology, fibrosis and treatment 35
Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases 35
Eosinophilic Interstitial Pneumonia 35
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys 35
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 35
Point of care antibody detection assays for past SARS-CoV-2 infection are accurate over the time 35
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: Results from the COVAD study 35
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study 35
Neck circumference as reliable predictor of mechanical ventilation support in adult inpatients with COVID-19: A multicentric prospective evaluation 35
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 34
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study 34
COVID-19 vaccination in autoimmune diseases (COVAD) study: Vaccine safety and tolerance in rheumatoid arthritis 34
Emerging potential for bisphosphonates in the treatment of axial spondyloarthritis 33
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 33
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives 33
COVID-19-Induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: Hypothesis regarding mechanism of intestinal damage associated with COVID-19 33
COVID-19 vaccination in autoimmune disease (COVAD) survey protocol 33
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected Patients 33
Vitamin D Impacts on Skeletal Muscle Dysfunction in Patients with COPD Promoting Mitochondrial Health 33
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study 33
Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis 32
Clinical, morphological features and prognostic factors associated with interstitial lung disease in primary Sjӧgren's syndrome: A systematic review from the Italian Society of Rheumatology 32
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 31
Totale 4.547
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.637
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.637
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.523 0 0 0 0 334 287 113 127 156 189 203 114
2025/20263.858 214 941 699 543 69 144 325 318 380 225 0 0
Totale 5.381